Mendota Financial Group’s BioLife Solutions BLFS Stock Holding History

Mendota Financial Group’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-4	Closed	-$101	–	482
2024 Q3	$101	Buy	+4	New	+$94	﹤0.01%	924

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

CRM

Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Mendota Financial Group's BLFS Position: Q4 2024 in Review

Mendota Financial Group sold out of BioLife Solutions (BLFS) in Q4 2024, closing a stake of 4 shares — an estimated $101 sold.

Mendota Financial Group first reported a position in BLFS in Q3 2024 and held it in 1 quarter. The position peaked at $101 in Q3 2024. 180 funds tracked by Wall St. Rank hold BLFS as of Q4 2024.

Mendota Financial Group reported no remaining BioLife Solutions position as of Q4 2024 after selling out during the quarter.
Mendota Financial Group sold 4 BioLife Solutions shares in Q4 2024, an estimated $101.
Mendota Financial Group first reported a position in BioLife Solutions in Q3 2024 and held it in 1 quarter.
Mendota Financial Group's BioLife Solutions position peaked at $101 in Q3 2024.
180 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2024.

Based on Mendota Financial Group's 13F filing for Q4 2024, filed 14 Jan 2025.